Back to products

LuciEntre 100 mg Capsule

Brand Name: LuciEntre

Molecule: Entrectinib

Strength: 100 mg

Quantity: 60 Capsules

Form: Capsule

Packaging Type: Bottle

Manufacturer/Marketed By: Lucius Pharma

Country of Origin: Laos

Request Pricing & Availability

Fill in your details below and our clinical team will get back to you with pricing & availability within 24 hours.

Similar Products

Product	Manufacturer / Marketed By	Price
LuciEntre 200 mg Capsule	Lucius Pharma	Ask for Price

Description

Active Ingredient: Each LuciEntre capsule contains Entrectinib 100mg. Indications: LuciEntre is a kinase inhibitor prescribed for the treatment of: ROS1-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC): For adult patients with ROS1-positive metastatic NSCLC, as confirmed by an FDA-approved test. NTRK Gene Fusion-Positive Solid Tumors: For adults and pediatric patients (12 years and older) with solid tumors that: Have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion (detected by an FDA-approved test) without known resistance mutations. Are metastatic or where surgery could cause severe complications. Have progressed after prior therapy or have no satisfactory alternative treatments. Note: The NTRK indication is approved under accelerated approval based on tumor response rate and durability. Continued approval may depend on further clinical trials confirming its benefits.